ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Olon has announced a $30 million expansion at its therapeutic peptide facility at the Settimo Torinese biotech center in Turin, Italy. The 2-year project includes adding a manufacturing line for small-volume peptides, primarily to support early clinical development of injectable drugs, and a large-scale production line. The investment will also support the addition of an R&D team at the site dedicated to peptide development and project scale-up.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter